PRTN3 and rheumatoid arthritis: The progressive improvement in autoantibody laboratory assays, together with the recognition of other possible autoantibody specificities beyond RF and ACPA, have led some authors to hypothesize that at least a proportion of autoantibody-negative RA is in fact incorrectly denominated seronegative [9].